StockData
Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc. (MRKR) stock

MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.85+0.02 (+1.98%)

Close on Nov 18, 2026Market cap $14.23MP/E –Yield –

Marker Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Marker Therapeutics's pe ratio was 1.0× on Oct 31, 2016.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2016Oct 31, 20161.0×–

More Marker Therapeutics figures

See a number that looks wrong?